SG11201401794YA - Selective androgen receptor modulators - Google Patents

Selective androgen receptor modulators

Info

Publication number
SG11201401794YA
SG11201401794YA SG11201401794YA SG11201401794YA SG11201401794YA SG 11201401794Y A SG11201401794Y A SG 11201401794YA SG 11201401794Y A SG11201401794Y A SG 11201401794YA SG 11201401794Y A SG11201401794Y A SG 11201401794YA SG 11201401794Y A SG11201401794Y A SG 11201401794YA
Authority
SG
Singapore
Prior art keywords
androgen receptor
receptor modulators
selective androgen
selective
modulators
Prior art date
Application number
SG11201401794YA
Inventor
Prabhakar Kondaji Jadhav
Ashraf Saeed
Jonathan Edward Green
Venkatesh Krishnan
Donald Paul Matthews
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47046879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201401794Y(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG11201401794YA publication Critical patent/SG11201401794YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
SG11201401794YA 2011-10-13 2012-10-05 Selective androgen receptor modulators SG11201401794YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161546711P 2011-10-13 2011-10-13
PCT/US2012/058824 WO2013055577A1 (en) 2011-10-13 2012-10-05 Selective androgen receptor modulators

Publications (1)

Publication Number Publication Date
SG11201401794YA true SG11201401794YA (en) 2014-09-26

Family

ID=47046879

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401794YA SG11201401794YA (en) 2011-10-13 2012-10-05 Selective androgen receptor modulators

Country Status (27)

Country Link
US (1) US8658693B2 (en)
EP (1) EP2766350B1 (en)
JP (1) JP6002228B2 (en)
KR (1) KR20140067102A (en)
CN (1) CN103842348B (en)
AP (1) AP2014007548A0 (en)
AR (1) AR088082A1 (en)
AU (1) AU2012321113B2 (en)
BR (1) BR112014008668A2 (en)
CA (1) CA2847889A1 (en)
CL (1) CL2014000895A1 (en)
CO (1) CO6910195A2 (en)
CR (1) CR20140156A (en)
DO (1) DOP2014000075A (en)
EA (1) EA201490519A1 (en)
EC (1) ECSP14013305A (en)
ES (1) ES2626820T3 (en)
GT (1) GT201400067A (en)
IL (1) IL231440A0 (en)
MX (1) MX2014004558A (en)
PE (1) PE20141669A1 (en)
PL (1) PL2766350T3 (en)
PT (1) PT2766350T (en)
SG (1) SG11201401794YA (en)
TN (1) TN2014000136A1 (en)
TW (1) TWI449686B (en)
WO (1) WO2013055577A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140045856A1 (en) 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
TW201534586A (en) * 2013-06-11 2015-09-16 Orion Corp Novel CYP17 inhibitors/antiandrogens
CA2929742C (en) 2013-12-04 2022-09-20 Evotec International Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
EP3140300B1 (en) 2014-05-07 2019-08-14 Evotec International GmbH Sulfoximine substituted quinazolines for pharmaceutical compositions
DK3497103T3 (en) 2016-08-15 2021-06-14 Pfizer PYRIDOPYRIMDINONE-CDK2 / 4/6 INHIBITORS
CN109952302B (en) 2016-09-02 2020-11-24 苏文生命科学有限公司 Positive allosteric modulators of muscarinic M1 receptors
BR112020004441B1 (en) 2017-09-18 2024-01-16 Basf Se COMPOUNDS OF FORMULA I, AGROCHEMICAL COMPOSITION, COATED SEED, USE OF COMPOUNDS AND NON-THERAPEUTIC METHOD OF FIGHTING FUNGUS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594405A (en) * 1968-05-17 1971-07-20 Du Pont Substituted pyranyl anilines as plant growth modifiers
ATE315555T1 (en) * 2001-05-11 2006-02-15 Pfizer Prod Inc THIAZOLE DERIVATIVES AND THEIR USE AS CDK INHIBITORS
US8519158B2 (en) * 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
MX2007014053A (en) * 2005-05-13 2008-02-05 Lilly Co Eli Substituted n-arylpyrrolidines as selective androgen receptor modulators.
EP1955697B1 (en) * 2005-11-30 2012-05-02 Astellas Pharma Inc. 2-aminobenzamide derivatives as vanilloid receptor 1 (vr1) inhibitors useful for the treatment of pain or bladder function disorder
EP2146967A2 (en) * 2007-04-16 2010-01-27 Serenex, Inc. Tetrahydroindole and tetrahydroindazole derivatives
CN101828200A (en) * 2007-10-19 2010-09-08 米歇尔·勒唐德尔-赫德伦 Methods of identifying environmentally friendly businesses or individuals
EP2260028B1 (en) * 2008-02-22 2014-05-07 Radius Health, Inc. Selective androgen receptor modulators

Also Published As

Publication number Publication date
DOP2014000075A (en) 2014-06-01
TN2014000136A1 (en) 2015-07-01
CN103842348A (en) 2014-06-04
WO2013055577A1 (en) 2013-04-18
CL2014000895A1 (en) 2014-08-22
TWI449686B (en) 2014-08-21
CN103842348B (en) 2015-08-19
EP2766350A1 (en) 2014-08-20
ES2626820T3 (en) 2017-07-26
GT201400067A (en) 2015-02-27
TW201329026A (en) 2013-07-16
KR20140067102A (en) 2014-06-03
PL2766350T3 (en) 2017-08-31
PT2766350T (en) 2017-05-22
PE20141669A1 (en) 2014-11-08
EA201490519A1 (en) 2014-09-30
MX2014004558A (en) 2014-08-01
AR088082A1 (en) 2014-05-07
AU2012321113B2 (en) 2015-07-09
ECSP14013305A (en) 2014-05-31
US8658693B2 (en) 2014-02-25
EP2766350B1 (en) 2017-04-05
IL231440A0 (en) 2014-04-30
US20130217762A1 (en) 2013-08-22
JP6002228B2 (en) 2016-10-05
JP2014530818A (en) 2014-11-20
CA2847889A1 (en) 2013-04-18
AP2014007548A0 (en) 2014-03-31
CO6910195A2 (en) 2014-03-31
AU2012321113A1 (en) 2014-03-27
BR112014008668A2 (en) 2017-04-25
CR20140156A (en) 2014-05-16

Similar Documents

Publication Publication Date Title
HK1195305A1 (en) Androgen receptor modulating carboxamides
EP2531029A4 (en) Selective androgen receptor modulators
EP2694053A4 (en) Selective androgen receptor modulators for treating diabetes
AP3338A (en) Glucagon receptor modulator
GB201213700D0 (en) Receptor antagnists II
IL227779A0 (en) Cannabinoid receptor modulators
IL251897A0 (en) Liver x receptor modulators
IL231440A0 (en) Selective androgen receptor modulators
HK1206333A1 (en) Liver receptor modulators
HK1208867A1 (en) Indolecarbonitriles as selective androgen receptor modulators
GB201004739D0 (en) Receptor modulators
HK1209744A1 (en) Novel selective androgen receptor modulators
GB201223053D0 (en) Receptor